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Hypertension is a worldwide disorder that contributes significantly to morbidity, mortality, and healthcare costs
in both developed and developing communities. A retrospective cohort study of hypertensive patients attending
the Internal Medicine continuity clinic at Nashville General Hospital (NGH) between January and December 2007
was conducted. Given the easy access to health care at NGH and affordable Blood pressure (BP) medications, we
explored the ability to achieve optimal BP control <140/90 mmHg and evaluated which factors are associated. Of
the 199 subjects, 59% achieved BP goal <140/90 mmHg. The mean BP was 139/80 mmHg. Health insurance
status was associated with SBP and DBP (All P < 0.046). Patients with health insurance had a 2.2 fold increased
odds of achieving BP control compared to patients without health insurance (P ¼ 0.025). Furthermore, the
number of BP medications used was significantly associated with SBP and DBP (All P < 0.003). Patients taking
more than three BP medications had a 58% reduced odds of achieving optimal BP control compared to patients
taking one medication (P ¼ 0.039). Ethnicity was not associated with achieving BP control. Our study revealed
the number of BP medications used and health insurance status, are factors associated with achieving BP control.1. Introduction
Hypertension is a worldwide disorder that contributes significantly to
morbidity, mortality, and healthcare costs in both developed and
developing communities. The prevalence of hypertension in U.S. adults
in 2009 was approximately 40% and the National Health and Nutrition
Examination Survey (NHANES) report has shown that this prevalence has
remained unchanged during the past 10 years [1–3]. The JNC 8 guide-
lines recommended goal for patients with uncomplicated hypertension is
an average systolic blood pressure (SBP) of less than 140 mm Hg and a
diastolic blood pressure (DBP) of less than 90 mm Hg for patients less
than 60 years [4]. For patients with certain co-morbid conditions that
increase cardiovascular risk such as diabetes mellitus and chronic kidney
disease), the goal BP is similar at less than 140/90 mm Hg [4]. However,
only about half of those with hypertension have their BP controlled
despite these recommendations [5].
Randomized controlled trials have convincingly shown that treat-
ment of hypertension reduces the risk of stroke, coronary heart disease,e, Department of Internal Medici
n).
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vier B.V. This is an open access arcongestive heart failure, and mortality associated with these conditions
[4,6]. Despite these, about 30% of patients with hypertension are not
being treated pharmacologically, and only about 55% of hypertensives
have their blood pressure under control [1]. Furthermore, achievement
of guideline-defined treatment goals has been shown to be useful in the
assessment of the quality of care [7,8].
Although awareness and treatment of hypertension have improved in
recent decades, those who have difficulties accessing health care are less
likely to have their BP controlled than those who have no barriers to
health care access [9,10]. In addition, awareness of hypertension is
higher among those who have adequate health care access because those
who have difficulties accessing healthcare may delay necessary health
care screenings [11]. No previous study have evaluated the factors
associated with BP control when easy access to health care is available to
hypertensive patients in the US.
The Nashville General Hospital (NGH) located in the Davidson county
area of the state of Tennessee, USA serves the residents of the county and
attends to all patients with or without health insurance. The hospital hasne, 1005 DB Todd Blvd, Nashville, TN 37208, USA.
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
Table 1
Demographics of the study population.
Demographics
Age, yrs. mean  SD 57  11
Gender, male n (%) 81 (41)
Ethnicity, Caucasians, n (%) 58 (29)
Health Insurance status, Yes, n (%) 136 (68)
History of Chronic Kidney disease, n (%) 23 (12)
History of Diabetes Mellitus, n (%) 90 (45)
No of Blood Pressure medications >4, n (%) 35 (18)
Systolic Blood Pressure, mmHg, Mean (95% CI) 139 (136–141)
Diastolic Blood Pressure, mmHg. Mean (95% CI) 80 (79–82)
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covers access to healthcare and purchase of medications at little or no
cost to the patients. Commonly used blood pressure medications are
available to patients for $4 for a 30 day supply at most retail pharmacies.
The primary goal of this study is to assess the ability to achieve target
blood pressure control amongst hypertensive patients attending the in-
ternal medicine clinic at NGH given the easy access to health care pa-
tients are afforded. The secondary goal of this study is to evaluate the
factors associated with achieving blood pressure control in the patients
attending the internal medicine clinic at NGH.
1.1. Methods
A retrospective chart review of patients attending the internal med-
icine clinic at NGH was carried out after appropriate approval has been
received from the Meharry Medical College (medical school affiliated
with NGH) Institutional Review Board (IRB). The inclusion criteria for
patients include: (1) age over 18 years, (2) continuous enrollment in the
internal medicine continuity clinic for more than 1 year, (3) seen in clinic
between January and December of 2007, (4) seen at least twice in the
clinic during the 12 months prior to data collection with documentation
of blood pressure measurement, (5) diagnosis and treatment for hyper-
tension. Patients with end stage renal disease on chronic hemodialysis
were excluded. Data from the medical records of these patients were
extracted and recorded on standardized data collection forms. Data
extracted include patient's age, sex, ethnicity, health insurance status,
number of antihypertensive medications, history of diabetes mellitus and
chronic kidney disease.
Blood pressures were obtained using a digital sphygmomanometer
with patient seated and arm placed at appropriate position and length.
Hypertension was considered controlled if blood pressure is at target goal
which is SBP of less than 140 mm Hg and a DBP of less than 90 mm Hg.
The list of BP medications used in the Internal Medicine clinic of
Nashville General included calcium channel blockers, diuretics, beta
blockers, angiotensin receptor blockers or angiotensin converting
enzyme inhibitors which are available to patients for $4 at most retail
pharmacies.
1.2. Statistical analysis
Continuous variables are presented as the mean  standard deviation
(SD for normally distributed variables and median (interquartile range)
for variables that are not normally distributed. Dichotomous variables
are presented as numbers and frequencies. For the primary outcome, the
proportion of patients achieving pre-set BP goals was computed. To test
the secondary hypothesis, univariate regression analysis was conducted
to assess the association of each of the collected covariates (age, sex,
ethnicity, health insurance status, the number of antihypertensive med-
ications, a diagnosis of diabetes, and a diagnosis of chronic kidney dis-
ease) and blood pressure control as a continuous variable, and as a
dichotomous variable of BP control of <140/90 mmHg. Multivariate
analysis exploring the effects of covariates (as earlier stated) on BP
control was conducted. Statistical analysis was conducted using the IBM
Statistical Package for Social Sciences (SPSS) version 21. Graphs were
produced using the Graph pad Prism software.
2. Results
2.1. Demographics
200 patients met the study criteria but one patient was excluded
because the blood pressure was incorrectly documented as a four digit
blood pressure measurement. Of the remaining 199 study patients, 59%
were female and the patient's age ranged from 22 to 98 years old with an
average of 57  11 years old. The study population was mostly African
American (68%) and 32% did not have any health insurance. Only 12%2of the study population had chronic kidney disease stage 3 or less and
45% of the population had diabetes mellitus. (Table 1). 55% of the study
population used at least two blood pressure medications.
2.2. Blood pressure control
The mean (95% CI) SBP of the entire study group was 139 mmHg
(136–141) mmHg while the mean (95% CI) diastolic blood pressure was
80 mmHg (79–82) mmHg. 61% of the study population achieved optimal
SBP control <140 mmHg and 82% of the study population achieved
optimal DBP control <90 mmHg. Overall, 59% of the study population
achieved optimal guideline directed BP goal <140/90 mmHg.
2.3. Health insurance status and blood pressure control
Health insurance status was associated with SBP control. Patients
without health insurance had higher SBP [Mean (95% CI; 141 (137–146)
mmHg] compared to patients with health insurance [Mean (95% CI; 137
(134–140) mmHg (P ¼ 0.046, Fig. 1). Health insurance status was also
associated with DBP. Patients without health insurance had significantly
higher DBP compared to patients with health insurance [Mean (95% CI;
84 (81–88) mmHg vs 78 (76–80) mmHg; P ¼ 0.003)]. Overall, patients
with health insurance had a 2.2 fold increased odds of achieving optimal
BP control less than 140/90 mmHg compared to patients without health
insurance (P ¼ 0.025).
2.4. Number of BP medications used and blood pressure control
In addition to the health insurance status of patients, the number of
blood pressure medications used was significantly associated with SBP
and DBP (All P < 0.003, Fig. 2). Patients taking three or more BP meds
had significantly higher SBP (Mean (95% CI; 143 (137–149) mmHg) and
DBP (Mean 95% CI; 82 (79–85) mmHg) compared to patients taking one
BPmedication [Mean SBP, 95% CI; 134 (130–138) mmHg andMean DBP
95% CI; 76 (73–80) mmHg respectively; All P < 0.003]. Furthermore,
patients taking more than three BP medications had a 58% reduced odds
of achieving adequate BP control less than 140/90 mmHg compared to
patients taking one medication (P ¼ 0.039).
3. Discussion
This significant findings of this research is that providing access to
hypertension patients and using blood pressure medications with an
average cost of $4 for a 30 day supply achieved BP control similar to the
national average. Furthermore, despite the easy access to health care
provided to these patients, health insurance status and number of blood
pressure medications were the factors affecting blood pressure control.
Achieving BP control can be done using inexpensive generic or
branded medications with comparable results. A third of patients that
attended the Internal medicine clinic at Nashville general Hospital did
not have health insurance and required use of generic medications with a
cost of about $4 for a 30 day supply. These generic medications were
deliberately prescribed to patients who could not afford the more
Fig. 1. Health Insurance status is associated with achieving systolic blood
pressure control. Systolic blood pressures are depicted as mean (95% confi-
dence interval).
Fig. 2. The number of blood pressure medication used is associated with
achieving systolic blood pressure control. Systolic blood pressures are depicted
as mean (95% confidence interval).
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achieved BP control <140/90 mmHg which is similar to the 2007 na-
tional average of 50%which was when this present study population was
sampled [12]. Additional factors except having easy access to their pri-
mary care physician or access to the medications prescribed are
responsible for the level of BP control achieved.
Health insurance status is an indirect measure of a patient's socio-
economic status. Health insurance status is usually dependent on age,
level of education, ethnicity and household income [13]. Patients that
have health insurance are also more likely to access health care [9–11].
However, given that the NGH Internal medicine clinic provided easy
access to all patients irrespective of their health insurance status, it was
surprising that this factor continued to play a major factor affecting BP
control even after removing effects of other known factors such as
ethnicity, age, sex, or co-morbid clinical conditions (chronic kidney
disease and diabetes mellitus). This indicates that a patient's socioeco-
nomic status plays a major role in achieving adequate BP control. This
may be due to the patient's level of education affecting their under-
standing of the severity of their illness and their adherence with BP3medications. Although we used drugs costing about $4 to purchase a 30
day supply, this may be unaffordable to these patients as they have low
household income. Further studies to explore the effect of adherence to
treatment and understanding of the disease condition on BP control will
be needed to confirm our findings.
Ethnicity is a well-established factor on the prevalence of hyperten-
sion, severity of hypertension, and achieving BP control as it is worse in
the African American population [3]. However, our study revealed that
when patients have health care access, ethnicity does not play a factor in
achieving BP control. Even with 68% of our study population being Af-
rican Americans, achieving optimal BP control <140/90 mmHg was not
different compared to the Caucasian patients that made up 29% of the
study population because everyone had access to health care. Further-
more, BP control is more suboptimal in African American patients with
additional co-morbidities like chronic kidney disease and diabetes mel-
litus than in Caucasian patients [14–17]. However, our study revealed
ethnicity is not a factor in achieving optimal BP control in these patients
with co-morbidities when access to health care and affordable BP med-
ications are provided.
The number of BP medications used by a patient is an indicator of
severity of hypertension. Patients with resistant hypertension require at
least three BP medications including a diuretic to achieve BP control.
Although, we do not have data about baseline BP before these patients
were started on BP medications, those requiring more BP medications
probably had more severe hypertension at baseline. Our study revealed
that the severity of BP is a factor in achieving BP control. These patients
did not necessarily have more co-morbid conditions as the effects of this
was adjusted for, but the severity of hypertension persistently contrib-
uted to optimal BP control. These patients may require additional BP
medications and/or other BP medication combinations to achieve better
BP control. A longer follow up in clinic may be needed to make these
changes and achieve optimal BP control.
We do not know if findings of this present study can be extrapolated
to other disease conditions like diabetes mellitus or hyperlipidemia.
Additional studies in these disease conditions will be needed to test this
hypothesis in a clinic setting like ours that affords easy health care access
and affordable medications. Furthermore, our study was limited to a one
year follow up in the clinic. A longer follow up may have revealed better
BP control as patients requiring more BP medication combinations may
achieve better control over time.
Our study have some limitations. We did not have a baseline BP
before patients were started on medications. However, patients had to
have been compliant with their clinic visits at least one year prior to
enrollment into our study, and the percentage of patients achieving
optimal BP control was similar to the national average. Furthermore, we
had a limited study population of about 200 patients, however, the level
of BP control was similar to the national average and our study popula-
tion comprised mostly African Americans which is a true reflection of the
ethnicity affected by the disease burden.
In conclusion, our study revealed optimal BP control can be achieved
using generic affordable BP medications when easy access to health care
is provided. Optimal BP control can be achieved without ethnicity or co
morbid conditions like chronic kidney disease or diabetes mellitus
playing a factor. However, the severity of hypertension and health in-
surance status may be a factor in achieving optimal BP control even when
easy access to health care is provided and affordable medications are
used.
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